These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29506849)

  • 1. Disparities in fertility-sparing surgery in adolescent and young women with stage I ovarian dysgerminoma.
    Stafman LL; Maizlin II; Dellinger M; Gow KW; Goldfarb M; Nuchtern JG; Langer M; Vasudevan SA; Doski JJ; Goldin AB; Raval M; Beierle EA
    J Surg Res; 2018 Apr; 224():38-43. PubMed ID: 29506849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.
    Turkmen O; Karalok A; Basaran D; Kimyon GC; Tasci T; Ureyen I; Tulunay G; Turan T
    J Adolesc Young Adult Oncol; 2017 Jun; 6(2):270-276. PubMed ID: 28085535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is fertility sparing surgery a treatment option for premenopausal patients with dysgerminoma?
    Iavazzo C; Vorgias G; Iavazzo PE; Gkegkes ID
    Bratisl Lek Listy; 2016; 117(12):738-740. PubMed ID: 28127973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility-preserving surgery for advanced stage ovarian germ cell tumors.
    Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
    Gynecol Oncol; 2017 Dec; 147(3):493-496. PubMed ID: 29021083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in the surgical management of malignant ovarian germcell tumors.
    Nasioudis D; Mastroyannis SA; Latif NA; Ko EM
    Gynecol Oncol; 2020 Apr; 157(1):89-93. PubMed ID: 32008791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Socioeconomic disparities affect survival in malignant ovarian germ cell tumors in AYA population.
    Bownes LV; Stafman LL; Maizlin II; Dellinger M; Gow KW; Goldin AB; Goldfarb M; Langer M; Raval MV; Doski JJ; Nuchtern JG; Vasudevan SA; Beierle EA
    J Surg Res; 2018 Feb; 222():180-186.e3. PubMed ID: 28988685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].
    Liu Q; Ding XL; Yang JX; Cao DY; Shen K; Lang JH; Zhang GN; Xin XY; Xie X; Zhang SL; Wu YM; Zhu GH; Wang J; Chen YL; Kong BH; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):188-92. PubMed ID: 23849941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant germ cell tumors of the ovary: a review of 41 cases and risk factors for recurrence.
    Topuz S; Iyibozkurt AC; Akhan SE; Keskin N; Yavuz E; Salihoglu Y; Bengisu E; Berkman S
    Eur J Gynaecol Oncol; 2008; 29(6):635-7. PubMed ID: 19115694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in Fertility-Sparing Treatment and Use of Assisted Reproductive Technology After a Diagnosis of Cervical, Ovarian, or Endometrial Cancer.
    Jorgensen K; Meernik C; Wu CF; Murphy CC; Baker VL; Jarmon P; Brady PC; Nitecki R; Nichols HB; Rauh-Hain JA
    Obstet Gynecol; 2023 Feb; 141(2):341-353. PubMed ID: 36649345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.
    Ghalleb M; Bouzaiene H; Slim S; Hadiji A; Hechiche M; Ben Hassouna J; Rahal K
    J Med Case Rep; 2017 Dec; 11(1):350. PubMed ID: 29248013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
    Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    Int J Gynecol Cancer; 2016 Jun; 26(5):859-64. PubMed ID: 27101582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?
    Shah R; Xia C; Krailo M; Amatruda JF; Arul SG; Billmire DF; Brady WE; Covens A; Gershenson DM; Hale JP; Hurteau J; Murray MJ; Nicholson JC; Olson TA; Pashankar F; Rodriguez-Galindo C; Shaikh F; Stark D; Frazier AL; Stoneham S
    Gynecol Oncol; 2018 Aug; 150(2):253-260. PubMed ID: 29884437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term oncological and reproductive outcomes of fertility-sparing cytoreductive surgery in females aged 25 years and younger with malignant ovarian germ cell tumors.
    Ertas IE; Taskin S; Goklu R; Bilgin M; Goc G; Yildirim Y; Ortac F
    J Obstet Gynaecol Res; 2014 Mar; 40(3):797-805. PubMed ID: 24320102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pure dysgerminoma of the ovary: a review of 45 well staged cases.
    Ayhan A; Bildirici I; Günalp S; Yuce K
    Eur J Gynaecol Oncol; 2000; 21(1):98-101. PubMed ID: 10726633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A primary malignant mixed germ cell tumor of the ovary].
    de Groot AW; Wagenaar SS
    Ned Tijdschr Geneeskd; 1978 Oct; 122(43):1657-60. PubMed ID: 81470
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-Term Outcomes and Factors Related to the Prognosis of Pure Ovarian Dysgerminoma: A Retrospective Study of 107 Cases.
    Xu T; Sun F; Li Y
    Gynecol Obstet Invest; 2021; 86(6):494-501. PubMed ID: 34794146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
    Nasioudis D; Chapman-Davis E; Frey MK; Witkin SS; Holcomb K
    J Gynecol Oncol; 2017 Nov; 28(6):e71. PubMed ID: 28758377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Results of fertility preserving operations in malignant ovarian tumors].
    Kleine W
    Zentralbl Gynakol; 1996; 118(6):317-21. PubMed ID: 8768006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disparities in stage at diagnosis among adults with testicular germ cell tumors in the National Cancer Data Base.
    Lerro CC; Robbins AS; Fedewa SA; Ward EM
    Urol Oncol; 2014 Jan; 32(1):23.e15-21. PubMed ID: 23395701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of pure stage one ovarian dysgerminoma in young women. Report of a case and review of the literature].
    Mazza D; Pozzi M; Sedati A; Vocaturo G
    Minerva Ginecol; 1999; 51(1-2):27-30. PubMed ID: 10230241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.